These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
336 related articles for article (PubMed ID: 29108133)
1. Targeted delivery of microRNA-199a-3p using self-assembled dipeptide nanoparticles efficiently reduces hepatocellular carcinoma in mice. Varshney A; Panda JJ; Singh AK; Yadav N; Bihari C; Biswas S; Sarin SK; Chauhan VS Hepatology; 2018 Apr; 67(4):1392-1407. PubMed ID: 29108133 [TBL] [Abstract][Full Text] [Related]
2. MiR-199a-3p regulates mTOR and c-Met to influence the doxorubicin sensitivity of human hepatocarcinoma cells. Fornari F; Milazzo M; Chieco P; Negrini M; Calin GA; Grazi GL; Pollutri D; Croce CM; Bolondi L; Gramantieri L Cancer Res; 2010 Jun; 70(12):5184-93. PubMed ID: 20501828 [TBL] [Abstract][Full Text] [Related]
3. MiR-199a-modified exosomes from adipose tissue-derived mesenchymal stem cells improve hepatocellular carcinoma chemosensitivity through mTOR pathway. Lou G; Chen L; Xia C; Wang W; Qi J; Li A; Zhao L; Chen Z; Zheng M; Liu Y J Exp Clin Cancer Res; 2020 Jan; 39(1):4. PubMed ID: 31898515 [TBL] [Abstract][Full Text] [Related]
4. Silence of lncRNA HEIH suppressed liver cancer cell growth and metastasis through miR-199a-3p/mTOR axis. Ma Y; Cao D; Li G; Hu J; Liu X; Liu J J Cell Biochem; 2019 Oct; 120(10):17757-17766. PubMed ID: 31144384 [TBL] [Abstract][Full Text] [Related]
5. MicroRNA-199a-3p regulates endometrial cancer cell proliferation by targeting mammalian target of rapamycin (mTOR). Wu D; Huang HJ; He CN; Wang KY Int J Gynecol Cancer; 2013 Sep; 23(7):1191-7. PubMed ID: 23851675 [TBL] [Abstract][Full Text] [Related]
6. MiR-199a-5p suppresses tumorigenesis by targeting clathrin heavy chain in hepatocellular carcinoma. Huang GH; Shan H; Li D; Zhou B; Pang PF Cell Biochem Funct; 2017 Mar; 35(2):98-104. PubMed ID: 28261837 [TBL] [Abstract][Full Text] [Related]
7. MicroRNA-199a-3p suppresses glioma cell proliferation by regulating the AKT/mTOR signaling pathway. Shen L; Sun C; Li Y; Li X; Sun T; Liu C; Zhou Y; Du Z Tumour Biol; 2015 Sep; 36(9):6929-38. PubMed ID: 25854175 [TBL] [Abstract][Full Text] [Related]
8. MiRNA199a-3p suppresses tumor growth, migration, invasion and angiogenesis in hepatocellular carcinoma by targeting VEGFA, VEGFR1, VEGFR2, HGF and MMP2. Ghosh A; Dasgupta D; Ghosh A; Roychoudhury S; Kumar D; Gorain M; Butti R; Datta S; Agarwal S; Gupta S; Krishna Dhali G; Chowdhury A; Schmittgen TD; Kundu GC; Banerjee S Cell Death Dis; 2017 Mar; 8(3):e2706. PubMed ID: 28358369 [TBL] [Abstract][Full Text] [Related]
9. MiR-199a/b-3p inhibits gastric cancer cell proliferation via down-regulating PAK4/MEK/ERK signaling pathway. Zeng B; Shi W; Tan G BMC Cancer; 2018 Jan; 18(1):34. PubMed ID: 29304764 [TBL] [Abstract][Full Text] [Related]
10. MiR-199-3p replacement affects E-cadherin expression through Notch1 targeting in hepatocellular carcinoma. Giovannini C; Fornari F; Dallo R; Gagliardi M; Nipoti E; Vasuri F; Coadă CA; Ravaioli M; Bolondi L; Gramantieri L Acta Histochem; 2018 Feb; 120(2):95-102. PubMed ID: 29249451 [TBL] [Abstract][Full Text] [Related]
11. Exosomes function as nanoparticles to transfer miR-199a-3p to reverse chemoresistance to cisplatin in hepatocellular carcinoma. Zhang K; Shao CX; Zhu JD; Lv XL; Tu CY; Jiang C; Shang MJ Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32463473 [TBL] [Abstract][Full Text] [Related]
12. Anti-invasion and anti-migration effects of miR-199a-3p in hepatocellular carcinoma are due in part to targeting CD151. Kim JH; Badawi M; Park JK; Jiang J; Mo X; Roberts LR; Schmittgen TD Int J Oncol; 2016 Nov; 49(5):2037-2045. PubMed ID: 27599545 [TBL] [Abstract][Full Text] [Related]
13. The hypoxia-related microRNA miR-199a-3p displays tumor suppressor functions in ovarian carcinoma. Kinose Y; Sawada K; Nakamura K; Sawada I; Toda A; Nakatsuka E; Hashimoto K; Mabuchi S; Takahashi K; Kurachi H; Lengyel E; Kimura T Oncotarget; 2015 May; 6(13):11342-56. PubMed ID: 25839163 [TBL] [Abstract][Full Text] [Related]
14. miR-199a-3p targets CD44 and reduces proliferation of CD44 positive hepatocellular carcinoma cell lines. Henry JC; Park JK; Jiang J; Kim JH; Nagorney DM; Roberts LR; Banerjee S; Schmittgen TD Biochem Biophys Res Commun; 2010 Dec; 403(1):120-5. PubMed ID: 21055388 [TBL] [Abstract][Full Text] [Related]
15. MicroRNA-34c-3p promotes cell proliferation and invasion in hepatocellular carcinoma by regulation of NCKAP1 expression. Xiao CZ; Wei W; Guo ZX; Zhang MY; Zhang YF; Wang JH; Shi M; Wang HY; Guo RP J Cancer Res Clin Oncol; 2017 Feb; 143(2):263-273. PubMed ID: 27704267 [TBL] [Abstract][Full Text] [Related]
16. PLGA-based dual targeted nanoparticles enhance miRNA transfection efficiency in hepatic carcinoma. Cai C; Xie Y; Wu L; Chen X; Liu H; Zhou Y; Zou H; Liu D; Zhao Y; Kong X; Liu P Sci Rep; 2017 Apr; 7():46250. PubMed ID: 28387375 [TBL] [Abstract][Full Text] [Related]
19. MiR-199a-3p enhances cisplatin sensitivity of cholangiocarcinoma cells by inhibiting mTOR signaling pathway and expression of MDR1. Li Q; Xia X; Ji J; Ma J; Tao L; Mo L; Chen W Oncotarget; 2017 May; 8(20):33621-33630. PubMed ID: 28422725 [TBL] [Abstract][Full Text] [Related]
20. miR-199a-3p inhibits cell proliferation and induces apoptosis by targeting YAP1, suppressing Jagged1-Notch signaling in human hepatocellular carcinoma. Ren K; Li T; Zhang W; Ren J; Li Z; Wu G J Biomed Sci; 2016 Nov; 23(1):79. PubMed ID: 27832779 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]